Essa Pharma (EPIX) Stock Overview

ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses the development of small molecule drugs for the treatment of prostate cancer. The company's lead candidate EPI-7386, an androgen receptor based resistance mechanisms that develop in patients with castration-resistant prostate cancer and metastatic castration-resistant prostate cancer. It has collaboration agreements with Bayer Consumer Care AG; Janssen Research & Development, LLC; and Astellas Pharma Inc. ESSA Pharma Inc. was incorporated in 2009 and is headquartered in Vancouver, Canada.

EPIX Stock Information

Symbol

EPIX

Address

999 West BroadwayVancouver, BC V5Z 1K5Canada

Founded

Trading hours

Website

https://www.essapharma.com

Country

🇨🇦 Canada

Phone Number

778 331 0962

Essa Pharma (EPIX) Price Chart

Essa Pharma Overview: Key Details and Summary

Stock data	2023	Change
Price	$6.77	N/A
Market Cap	$298.49M	N/A
Shares Outstanding	44.09M	0.12%
Employees	50.00	N/A
Shareholder Equity	145.63M	-12.86%

Valuation	2023	Change
P/E Ratio	-11.28	N/A
P/B Ratio	2.05	N/A

Growth	2023	Change
Return on Equity	-0.1825	N/A

Earnings	2023	Change
Revenue	$0	N/A
Earnings	-$26.58M	N/A
EPS	-0.6	N/A
Earnings Yield	-0.0886	N/A

Financial Strength	2023	Change
Total Assets	$149.12M	N/A
Total Debt	$80.33K	N/A
Cash on Hand	$148.08M	N/A
Debt to Equity	0.0240	68.04%
Cash to Debt	$1.84K	131.75%
Current Ratio	$42.57	-41.82%